Cargando…
Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728376/ https://www.ncbi.nlm.nih.gov/pubmed/35002282 http://dx.doi.org/10.2147/JIR.S351869 |
Ejemplares similares
-
Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis
por: Li, Xing, et al.
Publicado: (2021) -
Marked Reduction in 28-Day Mortality Among Elderly Patients with Severe Community-Acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial [Corrigendum]
Publicado: (2020) -
Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
por: Kaur, Savneet, et al.
Publicado: (2021) -
Corrigendum to Serum hepcidin levels in multiple sclerosis
Publicado: (2020) -
Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528]
por: González, R., et al.
Publicado: (2023)